Just last week, we reported that the 2025/26 NYS Budget Bill did not include a provision that would have increased the requirements for seeking Department of Health (DOH) approval of a material healthcare transaction (which generally means one that increases revenues from healthcare services by at least $25 million) [here]. We have previously
Legislation and Public Policy
Expanded Healthcare Transaction Notice/Review Dropped from Final 2025/26 NYS Budget Bill
We recently wrote about proposed legislation that would have substantially increased the existing reporting requirements for material healthcare transactions in NYS that have existed since Public Health Law (PHL) Article 45-A was enacted two years ago. We provided a detailed review of the current PHL 45-A here and here.
The proposed legislation would have…
Unpacking NY Laboratory Regulations and Recent Enforcement Trends
- Requirements to obtain a clinical lab permit and the exception for physician office
23andMe Bankruptcy Raises Legal Concerns Over Genetic Data Privacy
23andMe’s recent Chapter 11 bankruptcy filing has sparked significant concerns over the privacy and security of genetic data belonging to its 15 million customers.
Founded in 2006, 23andMe built its business around direct-to-consumer DNA testing, offering insights into ancestry and health risks. However, declining demand, financial struggles, and a major data breach in October 2023…
ADA Joins Coalition Seeking Tariff Exemption for Medical and Dental Supplies
The American Dental Association (ADA) has joined a coalition of other healthcare organizations in writing a letter to U.S. Trade Representative Jamieson Greer urging the Trump administration to exempt medical and dental supplies, equipment and devices from the President’s newly announced widespread tariffs.
The coalition’s letter explained, “Given the important role of our work in…
NYS Reinforces Its Scrutiny Over Healthcare Transactions
Overview
We recently discussed increasing state regulation of healthcare mergers and acquisitions in the face of the current Administration’s clear policy of federal deregulation. We noted that 15 states had implemented oversight laws for healthcare transactions. The stated purpose of these laws is to address two key issues: (1) to ensure that healthcare providers remain…
CTA Obligations for U.S. Companies Are No More
After many years of ups and downs, legal challenges, injunctions and deadline changes, the reporting obligations under the Corporate Transparency Act (CTA) have disappeared… for most.
On Friday, March 21, the Financial Crimes Enforcement Network (FinCEN) issued an interim final rule eliminating the requirement that U.S. companies and persons report beneficial ownership information (BOI) under…
Quality of Care Considerations in OIG’s Nursing Facility Compliance Guidance
Rivkin Radler’s John Queenan, Mary Aperance and Jeff Ehrhardt wrote the article “Quality of Care Considerations in OIG’s Nursing Facility Compliance Guidance” for the spring 2025 issue of USLAW Magazine.
Sign up to receive Rivkin Rounds at www.RivkinRounds.com.
State Laws Target Healthcare Investments as Feds Deregulate
Will the new administration’s federal deregulation be a boon for private equity investment in healthcare providers, or will the states be the “new sheriff in town”?
In the short time he has been in office, President Trump has made good on his campaign promises to shrink the roles and staff of many government agencies, with…
The Status of Providing Gender-Affirming Care to Minors in NY
In recent months, Executive Orders issued by the current Administration regarding gender-affirming care of minors have been the subject of much debate and litigation. The crux of these lawsuits is largely two Executive Orders: Executive Order 14187 (Protecting Children From Chemical and Surgical Mutilation) and Executive Order 14168 (Defending Women From Gender Ideology Extremism and…
